Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3T6 kinase activity	PRKCA PRKCB	6.91e-06	2	53	2	GO:0035403
GeneOntologyCellularComponent	actin cytoskeleton	FLNB DIAPH1 MYOZ2 PRKCB NTN1 LRRC7 DIAPH3 TEK NEXN	1.29e-05	576	53	9	GO:0015629
GeneOntologyCellularComponent	Z disc	FLNB MYOZ2 NEXN RYR3	5.82e-04	151	53	4	GO:0030018
GeneOntologyCellularComponent	supramolecular fiber	KIFAP3 FLNB DCDC2C DIAPH1 MYOZ2 DIAPH3 TEK NEXN BFSP1 RYR3	6.64e-04	1179	53	10	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KIFAP3 FLNB DCDC2C DIAPH1 MYOZ2 DIAPH3 TEK NEXN BFSP1 RYR3	6.99e-04	1187	53	10	GO:0099081
GeneOntologyCellularComponent	I band	FLNB MYOZ2 NEXN RYR3	8.29e-04	166	53	4	GO:0031674
GeneOntologyCellularComponent	PRC1 complex	CBX6 CBX8	1.05e-03	19	53	2	GO:0035102
Domain	Drf_DAD	DIAPH1 DIAPH3	2.19e-05	3	51	2	IPR010465
Domain	Protein_kinase_C_a/b/g	PRKCA PRKCB	2.19e-05	3	51	2	IPR014375
Domain	Drf_DAD	DIAPH1 DIAPH3	2.19e-05	3	51	2	PF06345
Domain	CBX7_C	CBX6 CBX8	7.27e-05	5	51	2	IPR033773
Domain	CBX7_C	CBX6 CBX8	7.27e-05	5	51	2	PF17218
Domain	DAD_dom	DIAPH1 DIAPH3	2.03e-04	8	51	2	IPR014767
Domain	DAD	DIAPH1 DIAPH3	2.03e-04	8	51	2	PS51231
Domain	Drf_GBD	DIAPH1 DIAPH3	2.60e-04	9	51	2	PF06371
Domain	FH3_dom	DIAPH1 DIAPH3	2.60e-04	9	51	2	IPR010472
Domain	GTPase-bd	DIAPH1 DIAPH3	2.60e-04	9	51	2	IPR010473
Domain	Drf_FH3	DIAPH1 DIAPH3	2.60e-04	9	51	2	PF06367
Domain	Drf_FH3	DIAPH1 DIAPH3	2.60e-04	9	51	2	SM01139
Domain	Drf_GBD	DIAPH1 DIAPH3	2.60e-04	9	51	2	SM01140
Domain	GBD/FH3_dom	DIAPH1 DIAPH3	3.96e-04	11	51	2	IPR014768
Domain	GBD_FH3	DIAPH1 DIAPH3	3.96e-04	11	51	2	PS51232
Domain	FH2	DIAPH1 DIAPH3	7.50e-04	15	51	2	PS51444
Domain	FH2_Formin	DIAPH1 DIAPH3	7.50e-04	15	51	2	IPR015425
Domain	FH2	DIAPH1 DIAPH3	7.50e-04	15	51	2	PF02181
Domain	FH2	DIAPH1 DIAPH3	7.50e-04	15	51	2	SM00498
Domain	Chromodomain_CS	CBX6 CBX8	1.09e-03	18	51	2	IPR023779
Domain	DAG/PE-bd	PRKCA PRKCB	1.49e-03	21	51	2	IPR020454
Domain	Chromo_domain	CBX6 CBX8	1.94e-03	24	51	2	IPR023780
Domain	Chromo	CBX6 CBX8	2.28e-03	26	51	2	PF00385
Domain	CHROMO_1	CBX6 CBX8	2.64e-03	28	51	2	PS00598
Domain	CHROMO_2	CBX6 CBX8	2.64e-03	28	51	2	PS50013
Domain	Chromodomain-like	CBX6 CBX8	3.44e-03	32	51	2	IPR016197
Domain	Chromo/shadow_dom	CBX6 CBX8	3.66e-03	33	51	2	IPR000953
Domain	CHROMO	CBX6 CBX8	3.66e-03	33	51	2	SM00298
Domain	Pkinase_C	PRKCA PRKCB	4.58e-03	37	51	2	IPR017892
Domain	Pkinase_C	PRKCA PRKCB	5.87e-03	42	51	2	PF00433
Domain	PDZ	IL16 LMO7 LRRC7	6.73e-03	141	51	3	PF00595
Domain	PDZ	IL16 LMO7 LRRC7	7.69e-03	148	51	3	SM00228
Domain	-	IL16 LMO7 LRRC7	7.98e-03	150	51	3	2.30.42.10
Domain	PDZ	IL16 LMO7 LRRC7	8.12e-03	151	51	3	PS50106
Domain	PDZ	IL16 LMO7 LRRC7	8.27e-03	152	51	3	IPR001478
Domain	AGC-kinase_C	PRKCA PRKCB	1.02e-02	56	51	2	IPR000961
Domain	AGC_KINASE_CTER	PRKCA PRKCB	1.02e-02	56	51	2	PS51285
Domain	S_TK_X	PRKCA PRKCB	1.02e-02	56	51	2	SM00133
Domain	C1_1	PRKCA PRKCB	1.06e-02	57	51	2	PF00130
Pathway	WP_AGERAGE_PATHWAY	DIAPH1 PRKCA PRKCB MMP13	3.19e-05	66	39	4	M39420
Pathway	WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE	UGCG PRKCA PRKCB	6.11e-05	28	39	3	M42536
Pathway	BIOCARTA_ION_PATHWAY	PRKCA PRKCB	7.42e-05	5	39	2	MM1574
Pathway	BIOCARTA_PLCD_PATHWAY	PRKCA PRKCB	7.42e-05	5	39	2	MM1587
Pathway	BIOCARTA_ION_PATHWAY	PRKCA PRKCB	7.42e-05	5	39	2	M22059
Pathway	BIOCARTA_PLCD_PATHWAY	PRKCA PRKCB	7.42e-05	5	39	2	M22080
Pathway	REACTOME_DISINHIBITION_OF_SNARE_FORMATION	PRKCA PRKCB	7.42e-05	5	39	2	M26920
Pathway	BIOCARTA_ERBB4_PATHWAY	PRKCA PRKCB	1.55e-04	7	39	2	MM1563
Pathway	BIOCARTA_PKC_PATHWAY	PRKCA PRKCB	1.55e-04	7	39	2	MM1572
Pathway	BIOCARTA_ERBB4_PATHWAY	PRKCA PRKCB	1.55e-04	7	39	2	M22043
Pathway	BIOCARTA_PKC_PATHWAY	PRKCA PRKCB	1.55e-04	7	39	2	M22057
Pathway	KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119	LCORL CBX6 CBX8	1.80e-04	40	39	3	M47917
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	2.07e-04	8	39	2	M47555
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	2.07e-04	8	39	2	M47479
Pathway	BIOCARTA_PLC_PATHWAY	PRKCA PRKCB	2.65e-04	9	39	2	M22029
Pathway	BIOCARTA_PLC_PATHWAY	PRKCA PRKCB	2.65e-04	9	39	2	MM1551
Pathway	WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION	PRKCA PRKCB MMP13	2.74e-04	46	39	3	M46450
Pathway	BIOCARTA_SRCRPTP_PATHWAY	PRKCA PRKCB	3.31e-04	10	39	2	MM1341
Pathway	BIOCARTA_AGPCR_PATHWAY	PRKCA PRKCB	3.31e-04	10	39	2	MM1352
Pathway	KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	3.31e-04	10	39	2	M47644
Pathway	WP_WNT_SIGNALING_WP363	PRKCA PRKCB TEK	3.72e-04	51	39	3	M39721
Pathway	BIOCARTA_CBL_PATHWAY	PRKCA PRKCB	4.04e-04	11	39	2	MM1360
Pathway	KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	4.04e-04	11	39	2	M47637
Pathway	BIOCARTA_SRCRPTP_PATHWAY	PRKCA PRKCB	4.04e-04	11	39	2	M10994
Pathway	BIOCARTA_MYOSIN_PATHWAY	PRKCA PRKCB	4.04e-04	11	39	2	M7014
Pathway	BIOCARTA_AGPCR_PATHWAY	PRKCA PRKCB	4.04e-04	11	39	2	M19829
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY	PRKCA PRKCB	4.84e-04	12	39	2	M47597
Pathway	KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	4.84e-04	12	39	2	M47649
Pathway	KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY	PRKCA PRKCB	4.84e-04	12	39	2	M47628
Pathway	BIOCARTA_CBL_PATHWAY	PRKCA PRKCB	4.84e-04	12	39	2	M16973
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY	PRKCA PRKCB	5.71e-04	13	39	2	M47656
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGDIB DIAPH1 DIAPH3 ARAP1	6.17e-04	142	39	4	MM15576
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY	PRKCA PRKCB	6.65e-04	14	39	2	M47383
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY	PRKCA PRKCB	6.65e-04	14	39	2	M47384
Pathway	PID_TCR_RAS_PATHWAY	PRKCA PRKCB	6.65e-04	14	39	2	M134
Pathway	BIOCARTA_TRKA_PATHWAY	PRKCA PRKCB	6.65e-04	14	39	2	M9134
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGDIB DIAPH1 DIAPH3 ARAP1	7.39e-04	149	39	4	M41805
Pathway	WP_ONCOSTATIN_M_SIGNALING	PRKCA PRKCB MMP13	7.59e-04	65	39	3	M39562
Pathway	BIOCARTA_CDMAC_PATHWAY	PRKCA PRKCB	7.65e-04	15	39	2	MM1358
Pathway	BIOCARTA_TRKA_PATHWAY	PRKCA PRKCB	7.65e-04	15	39	2	MM1523
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY	PRKCA PRKCB	7.65e-04	15	39	2	M47382
Pathway	REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA	PRKCA PRKCB	7.65e-04	15	39	2	M27360
Pathway	REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4	PRKCA PRKCB	7.65e-04	15	39	2	M27413
Pathway	BIOCARTA_MEF2D_PATHWAY	PRKCA PRKCB	8.73e-04	16	39	2	MM1483
Pathway	BIOCARTA_SPPA_PATHWAY	PRKCA PRKCB	8.73e-04	16	39	2	M8731
Pathway	BIOCARTA_CDMAC_PATHWAY	PRKCA PRKCB	8.73e-04	16	39	2	M4388
Pathway	BIOCARTA_CCR5_PATHWAY	PRKCA PRKCB	9.88e-04	17	39	2	M2349
Pathway	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	PRKCA PRKCB	9.88e-04	17	39	2	M5488
Pathway	BIOCARTA_CHEMICAL_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	MM1350
Pathway	BIOCARTA_CARDIACEGF_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	M7552
Pathway	BIOCARTA_MEF2D_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	M5290
Pathway	BIOCARTA_CALCINEURIN_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	MM1385
Pathway	BIOCARTA_CALCINEURIN_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	M3430
Pathway	BIOCARTA_CARDIACEGF_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	MM1479
Pathway	BIOCARTA_CHEMICAL_PATHWAY	PRKCA PRKCB	1.11e-03	18	39	2	M3873
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	PRKCA PRKCB OAS2	1.15e-03	75	39	3	M39568
Pathway	BIOCARTA_CCR3_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	MM1361
Pathway	KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY	PRKCA PRKCB	1.24e-03	19	39	2	M47596
Pathway	BIOCARTA_PAR1_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	MM1514
Pathway	BIOCARTA_CXCR4_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	MM1375
Pathway	BIOCARTA_CXCR4_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	M882
Pathway	BIOCARTA_CCR5_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	MM1453
Pathway	REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION	PRKCA PRKCB	1.24e-03	19	39	2	M27423
Pathway	BIOCARTA_PAR1_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	M3494
Pathway	BIOCARTA_CCR3_PATHWAY	PRKCA PRKCB	1.24e-03	19	39	2	M9152
Pathway	BIOCARTA_CREB_PATHWAY	PRKCA PRKCB	1.37e-03	20	39	2	MM1520
Pathway	BIOCARTA_NOS1_PATHWAY	PRKCA PRKCB	1.37e-03	20	39	2	MM1445
Pathway	BIOCARTA_EDG1_PATHWAY	PRKCA PRKCB	1.37e-03	20	39	2	MM1456
Pathway	BIOCARTA_ARENRF2_PATHWAY	PRKCA PRKCB	1.37e-03	20	39	2	M14339
Pathway	KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	1.52e-03	21	39	2	M47638
Pathway	BIOCARTA_NOS1_PATHWAY	PRKCA PRKCB	1.52e-03	21	39	2	M11650
Pathway	BIOCARTA_EDG1_PATHWAY	PRKCA PRKCB	1.66e-03	22	39	2	M10579
Pathway	BIOCARTA_CREB_PATHWAY	PRKCA PRKCB	1.66e-03	22	39	2	M9070
Pathway	BIOCARTA_ARENRF2_PATHWAY	PRKCA PRKCB	1.66e-03	22	39	2	MM1449
Pathway	BIOCARTA_EIF4_PATHWAY	PRKCA PRKCB	1.82e-03	23	39	2	MM1470
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	PRKCA PRKCB	1.98e-03	24	39	2	M27553
Pathway	BIOCARTA_EIF4_PATHWAY	PRKCA PRKCB	1.98e-03	24	39	2	M4791
Pathway	BIOCARTA_TPO_PATHWAY	PRKCA PRKCB	1.98e-03	24	39	2	M11520
Pathway	REACTOME_PCP_CE_PATHWAY	PSMC1 PRKCA PRKCB	2.07e-03	92	39	3	M27322
Pathway	BIOCARTA_TPO_PATHWAY	PRKCA PRKCB	2.15e-03	25	39	2	MM1519
Pathway	WP_FOCAL_ADHESION	FLNB DIAPH1 PRKCA PRKCB	2.15e-03	199	39	4	M39402
Pathway	KEGG_FOCAL_ADHESION	FLNB DIAPH1 PRKCA PRKCB	2.15e-03	199	39	4	M7253
Pathway	BIOCARTA_AT1R_PATHWAY	PRKCA PRKCB	2.32e-03	26	39	2	MM1346
Pathway	PID_VEGFR1_PATHWAY	PRKCA PRKCB	2.32e-03	26	39	2	M226
Pathway	KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY	PRKCA PRKCB	2.32e-03	26	39	2	M47557
Pathway	BIOCARTA_PYK2_PATHWAY	PRKCA PRKCB	2.32e-03	26	39	2	MM1431
Pathway	KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119	CBX6 CBX8	2.32e-03	26	39	2	M47923
Pathway	WP_HIPPO_SIGNALING_REGULATION	PRKCA PRKCB TEK	2.48e-03	98	39	3	M39830
Pathway	BIOCARTA_AT1R_PATHWAY	PRKCA PRKCB	2.51e-03	27	39	2	M14899
Pathway	BIOCARTA_PYK2_PATHWAY	PRKCA PRKCB	2.51e-03	27	39	2	M7739
Pathway	BIOCARTA_VEGF_PATHWAY	PRKCA PRKCB	2.51e-03	27	39	2	M12975
Pathway	BIOCARTA_GH_PATHWAY	PRKCA PRKCB	2.51e-03	27	39	2	M9043
Pathway	BIOCARTA_EGF_PATHWAY	PRKCA PRKCB	2.51e-03	27	39	2	M1909
Pathway	PID_IL8_CXCR1_PATHWAY	PRKCA PRKCB	2.69e-03	28	39	2	M252
Pathway	BIOCARTA_EGF_PATHWAY	PRKCA PRKCB	2.69e-03	28	39	2	MM1386
Pathway	BIOCARTA_PDGF_PATHWAY	PRKCA PRKCB	2.69e-03	28	39	2	M2529
Pathway	BIOCARTA_BIOPEPTIDES_PATHWAY	PRKCA PRKCB	2.89e-03	29	39	2	MM1356
Pathway	BIOCARTA_PDGF_PATHWAY	PRKCA PRKCB	2.89e-03	29	39	2	MM1452
Pathway	BIOCARTA_BIOPEPTIDES_PATHWAY	PRKCA PRKCB	2.89e-03	29	39	2	M13494
Pathway	WP_PDGFRBETA_PATHWAY	PRKCA PRKCB	2.89e-03	29	39	2	M39616
Pubmed	IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C.	IL16 PRKCA PRKCB	5.47e-07	11	53	3	8599832
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ARHGDIB FLNB LMO7 COBLL1 LRRC7 INAVA DIAPH3 USP15	2.15e-06	565	53	8	25468996
Pubmed	Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.	PRKCA PRKCB	2.28e-06	2	53	2	26660275
Pubmed	Insulin inhibits phagocytosis in normal human neutrophils via PKCalpha/beta-dependent priming of F-actin assembly.	PRKCA PRKCB	2.28e-06	2	53	2	16673150
Pubmed	Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity.	PRKCA PRKCB	2.28e-06	2	53	2	16517978
Pubmed	Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2.	PRKCA PRKCB	2.28e-06	2	53	2	25693686
Pubmed	The diaphanous inhibitory domain/diaphanous autoregulatory domain interaction is able to mediate heterodimerization between mDia1 and mDia2.	DIAPH1 DIAPH3	2.28e-06	2	53	2	17716977
Pubmed	Calcium-dependent isoforms of protein kinase C mediate posttetanic potentiation at the calyx of Held.	PRKCA PRKCB	2.28e-06	2	53	2	21658591
Pubmed	Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling.	PRKCA PRKCB	2.28e-06	2	53	2	24151077
Pubmed	Transient activation of PKC results in long-lasting detrimental effects on systolic [Ca2+]i in cardiomyocytes by altering actin cytoskeletal dynamics and T-tubule integrity.	PRKCA PRKCB	2.28e-06	2	53	2	29307535
Pubmed	Genes encoding catalytic subunits of protein kinase A and risk of spina bifida.	PRKCA PRKCB	2.28e-06	2	53	2	16080189
Pubmed	Receptor-specific regulation of atrial GIRK channel activity by different Ca2+-dependent PKC isoforms.	PRKCA PRKCB	2.28e-06	2	53	2	31525436
Pubmed	Unravelling the different functions of protein kinase C isoforms in platelets.	PRKCA PRKCB	2.28e-06	2	53	2	21596041
Pubmed	Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes.	PRKCA PRKCB	2.28e-06	2	53	2	25616575
Pubmed	PKCα and PKCβ cooperate functionally in CD3-induced de novo IL-2 mRNA transcription.	PRKCA PRKCB	2.28e-06	2	53	2	23439007
Pubmed	All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression.	PRKCA PRKCB	2.28e-06	2	53	2	33723318
Pubmed	Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling.	DIAPH1 DIAPH3	2.28e-06	2	53	2	10678165
Pubmed	Adaptive regulation maintains posttetanic potentiation at cerebellar granule cell synapses in the absence of calcium-dependent PKC.	PRKCA PRKCB	2.28e-06	2	53	2	22993418
Pubmed	The essentiality of PKCalpha and PKCbetaI translocation for CD14+monocyte differentiation towards macrophages and dendritic cells, respectively.	PRKCA PRKCB	2.28e-06	2	53	2	17455194
Pubmed	Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Cα and Protein Kinase Cβ.	PRKCA PRKCB	2.28e-06	2	53	2	27657532
Pubmed	Epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells induced by urinary proteins requires the activation of PKC-α and βI isozymes.	PRKCA PRKCB	2.28e-06	2	53	2	21323641
Pubmed	Dynamic interaction of formin proteins and cytoskeleton in mouse oocytes during meiotic maturation.	DIAPH1 DIAPH3	2.28e-06	2	53	2	20971793
Pubmed	Calcium-dependent isoforms of protein kinase C mediate glycine-induced synaptic enhancement at the calyx of Held.	PRKCA PRKCB	2.28e-06	2	53	2	23035091
Pubmed	Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells.	PRKCA PRKCB	2.28e-06	2	53	2	9486851
Pubmed	Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways.	PRKCA PRKCB	2.28e-06	2	53	2	16430878
Pubmed	Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells.	PRKCA PRKCB	2.28e-06	2	53	2	28415683
Pubmed	Inhibition of the calcium release-activated calcium (CRAC) current in Jurkat T cells by the HIV-1 envelope protein gp160.	PRKCA PRKCB	2.28e-06	2	53	2	11744714
Pubmed	cPKC-dependent sequestration of membrane-recycling components in a subset of recycling endosomes.	PRKCA PRKCB	2.28e-06	2	53	2	14527960
Pubmed	Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.	PRKCA PRKCB	6.83e-06	3	53	2	23434935
Pubmed	PKC α regulates netrin-1/UNC5B-mediated survival pathway in bladder cancer.	PRKCA NTN1	6.83e-06	3	53	2	24528886
Pubmed	Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes.	PRKCA PRKCB	6.83e-06	3	53	2	1324914
Pubmed	PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity.	ARHGDIB PRKCA	6.83e-06	3	53	2	22469974
Pubmed	[Effect of phenethyl isothiocyanate on expression of genes during differentiation process of mouse embryonic stem cells in vitro].	PRKCA NTN1	6.83e-06	3	53	2	19239004
Pubmed	A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.	PRKCA PRKCB	6.83e-06	3	53	2	24316392
Pubmed	Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals.	PRKCA PRKCB	6.83e-06	3	53	2	9814702
Pubmed	Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans.	PRKCA PRKCB	6.83e-06	3	53	2	16775601
Pubmed	Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.	PRKCA PRKCB	6.83e-06	3	53	2	17936705
Pubmed	Specific protein kinase C isoforms α and βI are involved in follicle-stimulating hormone-induced mouse follicle-enclosed oocytes meiotic resumption.	PRKCA PRKCB	6.83e-06	3	53	2	23028752
Pubmed	Disruption of the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 as an effector for Cdc42.	DIAPH1 DIAPH3	6.83e-06	3	53	2	12676083
Pubmed	Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice.	PRKCA PRKCB	6.83e-06	3	53	2	7760054
Pubmed	PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.	PRKCA NTN1	6.83e-06	3	53	2	23526078
Pubmed	Protein kinase C regulates rod photoreceptor differentiation through modulation of STAT3 signaling.	PRKCA PRKCB	6.83e-06	3	53	2	20237998
Pubmed	Tropomyosin concentration but not formin nucleators mDia1 and mDia3 determines the level of tropomyosin incorporation into actin filaments.	DIAPH1 DIAPH3	6.83e-06	3	53	2	31019238
Pubmed	S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells.	PRKCA PRKCB	6.83e-06	3	53	2	18162471
Pubmed	The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C.	PRKCA PRKCB	6.83e-06	3	53	2	12080070
Pubmed	Role of protein kinase C in selective inhibition of mouse retinal neurites during contacts with chondroitin sulfates.	PRKCA PRKCB	6.83e-06	3	53	2	18313852
Pubmed	Desmosomal adhesiveness is developmentally regulated in the mouse embryo and modulated during trophectoderm migration.	PRKCA PRKCB	6.83e-06	3	53	2	22819675
Pubmed	Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.	PRKCA PRKCB	6.83e-06	3	53	2	3755548
Pubmed	Phorbol diester-induced alterations in the expression of protein kinase C isozymes and their mRNAs. Analysis in wild-type and phorbol diester-resistant HL-60 cell clones.	PRKCA PRKCB	6.83e-06	3	53	2	1714454
Pubmed	Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.	PRKCA PRKCB	6.83e-06	3	53	2	32367578
Pubmed	A role for mammalian diaphanous-related formins in complement receptor (CR3)-mediated phagocytosis in macrophages.	DIAPH1 DIAPH3	6.83e-06	3	53	2	16303559
Pubmed	Differential interactions of the formins INF2, mDia1, and mDia2 with microtubules.	DIAPH1 DIAPH3	6.83e-06	3	53	2	21998204
Pubmed	Conventional protein kinase C plays a critical role in negative regulation of CD98-induced homotypic aggregation.	PRKCA PRKCB	6.83e-06	3	53	2	19895572
Pubmed	Mechanistic differences in actin bundling activity of two mammalian formins, FRL1 and mDia2.	DIAPH1 DIAPH3	6.83e-06	3	53	2	16556604
Pubmed	Spatiotemporal regulation of PKC via interactions with AKAP7 isoforms.	PRKCA PRKCB	6.83e-06	3	53	2	22670899
Pubmed	Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.	PRKCA PRKCB	6.83e-06	3	53	2	19556521
Pubmed	mDia formins form hetero-oligomers and cooperatively maintain murine hematopoiesis.	DIAPH1 DIAPH3	6.83e-06	3	53	2	38157491
Pubmed	Modulation of formin processivity by profilin and mechanical tension.	DIAPH1 DIAPH3	6.83e-06	3	53	2	29799413
Pubmed	Expression of protein kinase C isoenzymes alpha, betaI, and delta in subtypes of intercalated cells of mouse kidney.	PRKCA PRKCB	6.83e-06	3	53	2	16735462
Pubmed	Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.	PRKCA PRKCB	6.83e-06	3	53	2	30904392
Pubmed	PKC activation in Niemann pick C1 cells restores subcellular cholesterol transport.	PRKCA PRKCB	6.83e-06	3	53	2	23977398
Pubmed	Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts.	PRKCA PRKCB	6.83e-06	3	53	2	19066285
Pubmed	The filamentous actin cross-linking/bundling activity of mammalian formins.	DIAPH1 DIAPH3	6.83e-06	3	53	2	18835565
Pubmed	Essential and nonredundant roles for Diaphanous formins in cortical microtubule capture and directed cell migration.	DIAPH1 DIAPH3	6.83e-06	3	53	2	24403606
Pubmed	Calcium-Dependent Protein Kinase C Is Not Required for Post-Tetanic Potentiation at the Hippocampal CA3 to CA1 Synapse.	PRKCA PRKCB	6.83e-06	3	53	2	27307229
Pubmed	Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain.	PRKCA PRKCB	1.36e-05	4	53	2	9244383
Pubmed	Phosphorylation of p300 at serine 89 by protein kinase C.	PRKCA PRKCB	1.36e-05	4	53	2	11020388
Pubmed	STIM1 calcium sensor is required for activation of the phagocyte oxidase during inflammation and host defense.	PRKCA PRKCB	1.36e-05	4	53	2	24493668
Pubmed	Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes.	PRKCA PRKCB	1.36e-05	4	53	2	26404773
Pubmed	Protein kinase C phosphorylation of syntaxin 4 in thrombin-activated human platelets.	PRKCA PRKCB	1.36e-05	4	53	2	10856305
Pubmed	Regulation of spontaneous meiosis resumption in mouse oocytes by various conventional PKC isozymes depends on cellular compartmentalization.	PRKCA PRKCB	1.36e-05	4	53	2	15367584
Pubmed	Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cells.	PRKCA PRKCB	1.36e-05	4	53	2	15499829
Pubmed	Peptidyl-prolyl isomerase Pin1 controls down-regulation of conventional protein kinase C isozymes.	PRKCA PRKCB	1.36e-05	4	53	2	22318721
Pubmed	Protein kinase C phosphorylation of threonine at position 888 in Ca2+o-sensing receptor (CaR) inhibits coupling to Ca2+ store release.	PRKCA PRKCB	1.36e-05	4	53	2	9694886
Pubmed	Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7.	FLNB PRKCA	1.36e-05	4	53	2	23401860
Pubmed	EphA4-dependent axon retraction and midline localization of Ephrin-B3 are disrupted in the spinal cord of mice lacking mDia1 and mDia3 in combination.	DIAPH1 DIAPH3	1.36e-05	4	53	2	23890216
Pubmed	Cloning of a mouse protein kinase A catalytic subunit pseudogene and chromosomal mapping of C subunit isoforms.	PRKCA PRKCB	1.36e-05	4	53	2	7873880
Pubmed	Characterization of a 7.5-kDa protein kinase C substrate (RC3 protein, neurogranin) from rat brain.	PRKCA PRKCB	1.36e-05	4	53	2	8080473
Pubmed	Rho activation of mDia formins is modulated by an interaction with inverted formin 2 (INF2).	DIAPH1 DIAPH3	1.36e-05	4	53	2	21278336
Pubmed	Nanomolar amyloid beta protein activates a specific PKC isoform mediating phosphorylation of MARCKS in Neuro2A cells.	PRKCA PRKCB	1.36e-05	4	53	2	11930178
Pubmed	Nuclear actin network assembly by formins regulates the SRF coactivator MAL.	DIAPH1 DIAPH3	1.36e-05	4	53	2	23558171
Pubmed	Cell invasion of Yersinia pseudotuberculosis by invasin and YadA requires protein kinase C, phospholipase C-gamma1 and Akt kinase.	PRKCA PRKCB	1.36e-05	4	53	2	19681907
Pubmed	Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication.	PRKCA PRKCB	1.36e-05	4	53	2	10871288
Pubmed	PRK1 phosphorylates MARCKS at the PKC sites: serine 152, serine 156 and serine 163.	PRKCA PRKCB	1.36e-05	4	53	2	8557118
Pubmed	Physiological regulation of Munc18/nSec1 phosphorylation on serine-313.	PRKCA PRKCB	1.36e-05	4	53	2	12950453
Pubmed	Phosphorylation of Munc-18/n-Sec1/rbSec1 by protein kinase C: its implication in regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin.	PRKCA PRKCB	1.36e-05	4	53	2	8631738
Pubmed	Triggering Ras signalling by intracellular Francisella tularensis through recruitment of PKCα and βI to the SOS2/GrB2 complex is essential for bacterial proliferation in the cytosol.	PRKCA PRKCB	1.36e-05	4	53	2	20618341
Pubmed	Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C.	PRKCA PRKCB	1.36e-05	4	53	2	7499337
Pubmed	Presynaptic Short-Term Plasticity Persists in the Absence of PKC Phosphorylation of Munc18-1.	PRKCA PRKCB	1.36e-05	4	53	2	34290081
Pubmed	Phosphorylation of eIF-4E on serine 209 by protein kinase C is inhibited by the translational repressors, 4E-binding proteins.	PRKCA PRKCB	1.36e-05	4	53	2	8662663
Pubmed	Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition.	PRKCA PRKCB	1.36e-05	4	53	2	24401212
Pubmed	Loss of a Rho-regulated actin nucleator, mDia2, impairs cytokinesis during mouse fetal erythropoiesis.	DIAPH1 DIAPH3	1.36e-05	4	53	2	24239357
Pubmed	Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling.	PRKCA PRKCB	1.36e-05	4	53	2	11063746
Pubmed	Regulation of ARNO nucleotide exchange by a PH domain electrostatic switch.	PRKCA PRKCB	1.36e-05	4	53	2	10531036
Pubmed	A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells.	PRKCA PRKCB	2.27e-05	5	53	2	7513693
Pubmed	Signalling Pathways Mediating the Effects of CD40-Activated CD40L Reverse Signalling on Inhibitory Medium Spiny Neuron Neurite Growth.	PRKCA PRKCB	2.27e-05	5	53	2	33917019
Pubmed	Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling.	PRKCA PRKCB	2.27e-05	5	53	2	11123317
Pubmed	RhoD activated by fibroblast growth factor induces cytoneme-like cellular protrusions through mDia3C.	DIAPH1 DIAPH3	2.27e-05	5	53	2	23034183
Pubmed	PKCα integrates spatiotemporally distinct Ca2+ and autocrine BDNF signaling to facilitate synaptic plasticity.	PRKCA PRKCB	2.27e-05	5	53	2	30013171
Pubmed	Identification of the cAMP-dependent protein kinase and protein kinase C phosphorylation sites within the major intracellular domains of the beta 1, gamma 2S, and gamma 2L subunits of the gamma-aminobutyric acid type A receptor.	PRKCA PRKCB	2.27e-05	5	53	2	1321150
Cytoband	12q14	OSBPL8 USP15	7.42e-05	11	54	2	12q14
GeneFamily	Chromobox family	CBX6 CBX8	6.91e-05	8	29	2	976
GeneFamily	C2 domain containing protein kinases	PRKCA PRKCB	1.11e-04	10	29	2	835
GeneFamily	PDZ domain containing	IL16 LMO7 LRRC7	1.81e-03	152	29	3	1220
GeneFamily	Ubiquitin specific peptidases	USP40 USP15	3.63e-03	56	29	2	366
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGDIB AFF2 OSBPL8 PRKCB OAS2 MYBL2	5.72e-08	169	54	6	203971cceeba150d0e8891c92662545e84c77837
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	9.77e-08	185	54	6	f4588468e8654363f48adbe427dff10f16f1c7fe
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	9.77e-08	185	54	6	3cb816fc9541c04b4436e21d984216cfbbacff98
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	9.77e-08	185	54	6	c2e70405969616c28fb6379ee318e17bbcef7b49
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	1.01e-07	186	54	6	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	1.01e-07	186	54	6	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	1.01e-07	186	54	6	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	1.01e-07	186	54	6	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	1.01e-07	186	54	6	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	Mild_COVID-19-Myeloid-pDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	FLNB KCTD19 COBLL1 UGCG PRKCB MYBL2	1.04e-07	187	54	6	99c3c4a7b9179dce7982dc6516d561c952abc80e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ANOS1 CBX6 NTN1 LRRC7 NEXN RYR3	1.07e-07	188	54	6	74f7d216209cabdc96b2d46685b0ae017fdcc8fc
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLNB CBX6 COBLL1 UGCG PRKCB MYBL2	1.33e-07	195	54	6	06051de72b5c1e0d483a28b14dabd247dfca0ed9
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLNB CBX6 COBLL1 UGCG PRKCB MYBL2	1.33e-07	195	54	6	3aa44633c72658545aa2b35bf9d532c62f36a451
ToppCell	10x5'-Liver-Myeloid_Dendritic-pDC\|Liver / Manually curated celltypes from each tissue	FLNB KCTD19 COBLL1 UGCG MYBL2	1.76e-06	166	54	5	24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44
ToppCell	B_cell\|World / lung cells shred on cell class, cell subclass, sample id	FLNB IL16 AFF2 PRKCB MYBL2	1.98e-06	170	54	5	cec4090ba6a9c934d5f6f9e4aa7823f3713319b7
ToppCell	BAL-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLNB COBLL1 UGCG PRKCB MYBL2	2.22e-06	174	54	5	ab654e87c7eab7f33adc61be7a86da5c4d88008d
ToppCell	BAL-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB COBLL1 UGCG PRKCB MYBL2	2.22e-06	174	54	5	d9bccff5258c4277bdd1edbd87e17c327ec125e8
ToppCell	BAL-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB COBLL1 UGCG PRKCB MYBL2	2.22e-06	174	54	5	2453419842fd22d066631615403393bfe4449bb8
ToppCell	BAL-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB COBLL1 UGCG PRKCB MYBL2	2.28e-06	175	54	5	6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8
ToppCell	BAL-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB COBLL1 UGCG PRKCB MYBL2	2.28e-06	175	54	5	6839ee3bb4457d13cb08ca8eb79ae33ddd256783
ToppCell	BAL-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB COBLL1 UGCG PRKCB MYBL2	2.28e-06	175	54	5	9d6135e183179968555670abec39dff9da2c3219
ToppCell	Control-Lymphoid-pDC\|Control / Condition, Lineage and Cell class	FLNB COBLL1 UGCG PRKCB MYBL2	2.34e-06	176	54	5	5de16ff65476bde8b23322a44e11412e14f1bafe
ToppCell	Control-Myeloid-pDC\|Control / Disease group,lineage and cell class （2021.01.30）	FLNB COBLL1 UGCG PRKCB MYBL2	2.34e-06	176	54	5	baa3563973ea1a351fe028f55828463d2a51bf1a
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-pDC\|bone_marrow / Manually curated celltypes from each tissue	FLNB KCTD19 COBLL1 UGCG MYBL2	2.91e-06	184	54	5	2817d530863e85dfdcd143b7a3dc5fc58a9cd98b
ToppCell	(7)_MNP-(7)_DC_plasmacytoid\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	FLNB CBX6 COBLL1 UGCG MYBL2	2.99e-06	185	54	5	9f67f652488e17075a372e2a2e1100f6d0af6d7d
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FLNB COBLL1 UGCG PRKCB MYBL2	2.99e-06	185	54	5	308a98f111895071d8772bc010554471cc12fab2
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	31df1eafa3010bc1be6fc4d4689f1393d69b6b13
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	eaa431ccd4cdd36fe06a44987603ec9979025aa8
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	b95be984e308d4f9061274a35995ec558d434e74
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	8f7949740286f64e034d1eb533ebc2c6f71ae966
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	95c7318e521fb6aa02e244b1e81e6b2a62107756
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	b70cd94c651b56dcf2e55554533a5f1130845390
ToppCell	control-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	fccee4cfcc887358cf916d974f29627095b5ad9c
ToppCell	COVID-19_Severe-Myeloid-pDC\|COVID-19_Severe / Disease group, lineage and cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.07e-06	186	54	5	3db5ed69d49e5d79f990aca0295ddce4c297a05c
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.24e-06	188	54	5	89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.24e-06	188	54	5	de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCell	COVID-19_Mild-pDC\|COVID-19_Mild / Disease condition and Cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.24e-06	188	54	5	62d33d2990d4a2d32bd0863147e47f656df1966e
ToppCell	COVID-19_Severe-pDC\|World / disease group, cell group and cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.24e-06	188	54	5	4c8e328b8206120708b05ea3c5865a0200dc5c4e
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.24e-06	188	54	5	879054b780378ae05be68e597c77c931bf0ade03
ToppCell	COVID-19_Mild-pDC-\|COVID-19_Mild / Disease condition and Cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.24e-06	188	54	5	a75c2cf2f8dae343c13aaa66b637658b935ed10a
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.32e-06	189	54	5	209cae68d78c8f72479b169e27c3ff7e143adece
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANOS1 CBX6 NTN1 LRRC7 RYR3	3.32e-06	189	54	5	da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.32e-06	189	54	5	a9ad1fb12304541f909dd0eeac9b9eb28c31fd41
ToppCell	COVID-19_Mild-Myeloid-pDC\|COVID-19_Mild / Disease group, lineage and cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.32e-06	189	54	5	c6cfd6aa21c19f2c62d80218bbc924e14e82aada
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB KCTD19 COBLL1 UGCG MYBL2	3.32e-06	189	54	5	98ca646231fbd5f29827c2dd31ac4503026bad7d
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGDIB KCTD19 DIAPH3 ANKRD55 MYBL2	3.41e-06	190	54	5	b65383e256b04122500b742caeed0b807793851e
ToppCell	COVID-19_Severe-pDC\|COVID-19_Severe / disease group, cell group and cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.41e-06	190	54	5	c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGDIB KCTD19 DIAPH3 ANKRD55 MYBL2	3.41e-06	190	54	5	89095d3e023269d89c82e3a73550f869e3f34201
ToppCell	COVID-19_Moderate-pDC\|World / disease group, cell group and cell class	FLNB KCTD19 COBLL1 UGCG MYBL2	3.49e-06	191	54	5	93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	LMO7 MYOZ2 NTN1 LRRC7 NEXN	3.49e-06	191	54	5	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LMO7 COBLL1 DIAPH1 PRKCA NTN1	3.59e-06	192	54	5	f7e7491426bbd6ed29a465b58bf67acb93dbb90a
ToppCell	Biopsy_Other_PF-Immune-pDCs\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IL16 KCTD19 UGCG PRKCB MYBL2	4.06e-06	197	54	5	598a130eb7afb1bb95da64a964218362627feb49
ToppCell	(5)_Dendritic_cell-(54)_pDC\|(5)_Dendritic_cell / shred on Cell_type and subtype	FLNB COBLL1 UGCG PRKCB MYBL2	4.17e-06	198	54	5	fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8
ToppCell	Sepsis-Int-URO-Others-RBC\|Int-URO / Disease, condition lineage and cell class	FLNB LMO7 COBLL1 UGCG MYBL2	4.17e-06	198	54	5	29203aaa5c1844f72289e03f585cd5e7fc498a9a
ToppCell	Sepsis-Int-URO-Others\|Int-URO / Disease, condition lineage and cell class	FLNB LMO7 COBLL1 UGCG MYBL2	4.17e-06	198	54	5	67f721ea8e60042317ba12efd584f56b07cfb29d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGDIB AFF2 PRKCA PRKCB RYR3	4.37e-06	200	54	5	9156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGDIB AFF2 PRKCA PRKCB RYR3	4.37e-06	200	54	5	566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCell	COVID_non-vent-Lymphocytic-Dendritic-pDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	FLNB KCTD19 COBLL1 UGCG	4.24e-05	160	54	4	61f4cb4eb4313d8318aadbb99595a6cb7fd919f7
ToppCell	COVID_non-vent-Lymphocytic-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	FLNB KCTD19 COBLL1 UGCG	4.24e-05	160	54	4	34b4f710cfcb6ec370b8b074f3cbfe272f392cec
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGDIB IL16 LRRC7 DIAPH3	4.45e-05	162	54	4	e81dec1db8e5a808d96e58410c91961e5d065c94
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UGCG PRKCB ANKRD55 MYBL2	4.45e-05	162	54	4	86a0b9dabd150dc993bfc0f3344804de7f8e4042
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGDIB IL16 LRRC7 DIAPH3	4.45e-05	162	54	4	d19b469f64c9064cfb82dadb6c8135e28949a02a
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGDIB IL16 LRRC7 DIAPH3	4.45e-05	162	54	4	10c2aa047f33f48e4abe676236bbdb593079dd1d
ToppCell	356C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FLNB COBLL1 UGCG LRRC7	4.67e-05	164	54	4	fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CBX6 UGCG PRKCB MYBL2	5.13e-05	168	54	4	59b698f58cb206f0f8f0e8ad72b445d14ba24728
ToppCell	B_cells-pDCs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	FLNB KCTD19 UGCG MYBL2	5.13e-05	168	54	4	dc8f94424f60ab56facdcffa969e7f3466ee1b6e
ToppCell	(3)_MNP-(3)_DC_plasmacytoid\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	FLNB COBLL1 UGCG MYBL2	5.13e-05	168	54	4	13c160ea1a19b47d2e7e2dae818c8dcde4e3e377
ToppCell	Healthy_Control-Lymphoid-pDC\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	FLNB COBLL1 PRKCB MYBL2	5.25e-05	169	54	4	a4e9b8b2f0338203455ba941b8f99bf4884d26f0
ToppCell	Healthy_Control-Lymphoid-pDC-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	FLNB COBLL1 PRKCB MYBL2	5.25e-05	169	54	4	338ce99897cb522b86edd603f75bc15ec4dfcda3
ToppCell	343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ANOS1 DIAPH3 RYR3 MYBL2	5.49e-05	171	54	4	4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc
ToppCell	COVID-pDC\|COVID / Condition, Cell_class and T cell subcluster	KCTD19 COBLL1 UGCG MYBL2	5.62e-05	172	54	4	3ecbb000495dde32f6153ef6bdea9c8802ff3985
ToppCell	COVID-pDC-\|COVID / Condition, Cell_class and T cell subcluster	KCTD19 COBLL1 UGCG MYBL2	5.62e-05	172	54	4	a7827faa1afab51fdaf0cb1a2babcd2e00d411e5
ToppCell	RSV-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	IL16 OAS2 ZNF683 CCDC92	6.01e-05	175	54	4	ff3a27f512a3a710ebc863b7b75cce8167d5440b
ToppCell	RSV-Healthy-1\|RSV / Virus stimulation, Condition and Cluster	IL16 OAS2 ZNF683 CCDC92	6.01e-05	175	54	4	ca52b99b03535a5b3a2751d6981708dc5b255b91
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FLNB COBLL1 UGCG MYBL2	6.01e-05	175	54	4	97fe431f224b592b3076632d101e19136c138dcc
ToppCell	mild-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	KCTD19 COBLL1 UGCG MYBL2	6.14e-05	176	54	4	59a9c262c252b7d220a025837922d98e9d6b0a24
ToppCell	390C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	COBLL1 ZNF683 CBX8 MYBL2	6.14e-05	176	54	4	aab9603b7943b7f7243eb6190ebba998566196f3
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGDIB IL16 ZNF683 ANKRD55	6.28e-05	177	54	4	bb496fbec7cacc52847abe2b2714249c47879763
ToppCell	Healthy/Control-pDC\|Healthy/Control / Disease group and Cell class	FLNB COBLL1 UGCG MYBL2	6.42e-05	178	54	4	072b346c6bbd63f00efaceda486400a669b3ec48
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLNB COBLL1 UGCG MYBL2	6.56e-05	179	54	4	124da6f882968dc0d05f3edd8f3b4d61617cc214
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 UGCG PRKCB MYBL2	6.56e-05	179	54	4	4808469096cd6bec2bdfcf4fc55aa324757600c3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLNB COBLL1 UGCG MYBL2	6.56e-05	179	54	4	edc5ef693dc4e7ea70717b77fb908fc784dce3a2
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANOS1 LMO7 NEXN MYORG	6.56e-05	179	54	4	d5e3e7f1cd8f683f39a7416f12af7e766dcbead8
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FLNB COBLL1 TEK MYORG	6.56e-05	179	54	4	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 UGCG PRKCB MYBL2	6.56e-05	179	54	4	4d55718c6afd8a038d93cc77b9b08171dab9976f
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 UGCG PRKCB MYBL2	6.70e-05	180	54	4	6a2366d76276452141db1bd93013a9503525f574
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH3 COG5 CBX8 MYBL2	6.70e-05	180	54	4	87347af8f28cf7c486c19f3f98c0afb022c323b5
ToppCell	mild-Myeloid-pDC\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	KCTD19 COBLL1 UGCG MYBL2	6.70e-05	180	54	4	38614155fa537d0defda914c531c697be0ef06d8
ToppCell	moderate-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FLNB COBLL1 UGCG MYBL2	6.70e-05	180	54	4	1d8df7df03a71f49d6683554d3c948ce90dda42e
ToppCell	AT1_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	ANOS1 LMO7 DIAPH3 NEXN	6.70e-05	180	54	4	e1964002681f80d8d62406b6ee52a01e1829ccf2
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|tumor_Lung / Location, Cell class and cell subclass	COBLL1 UGCG PRKCB MYBL2	6.85e-05	181	54	4	c864ffeb9234b8c29754afc91c85a972889617f4
ToppCell	Healthy/Control-pDC\|World / Disease group and Cell class	FLNB COBLL1 UGCG MYBL2	7.00e-05	182	54	4	97e0eee10905f2cf2bebb09e474629fc224f4397
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCTD19 COBLL1 UGCG MYBL2	7.00e-05	182	54	4	9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	ANOS1 LMO7 DIAPH3 NEXN	7.00e-05	182	54	4	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNB LMO7 NTN1 INAVA	7.00e-05	182	54	4	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCTD19 COBLL1 UGCG MYBL2	7.00e-05	182	54	4	4602a98df7045e2c70b7560abfba9b444fbd5d30
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LMO7 CBX6 NTN1 TEK	7.15e-05	183	54	4	6f8f997ffc9eaebca2683de125b6069d07c07d26
ToppCell	normal_Lung-B_lymphocytes-GrB-secreting_B_cells\|normal_Lung / Location, Cell class and cell subclass	COBLL1 UGCG PRKCB MYBL2	7.15e-05	183	54	4	c930b957d16f9b0904b6c424acd914532e5cc137
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLNB COBLL1 UGCG MYBL2	7.15e-05	183	54	4	3b123571e10c132227aff65648b4b3c6acb4bd00
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLNB COBLL1 UGCG MYBL2	7.15e-05	183	54	4	df6fd0927b6e4cf9a1583969a68096e4bccfbace
Drug	12-hydroxydaphnetoxin	PRKCA PRKCB	5.32e-06	2	53	2	CID000099841
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	ARHGDIB DIAPH1 OAS2 CBX8 BFSP1 ARAP1	6.18e-06	196	53	6	4403_DN
Drug	octahydromezerein	PRKCA PRKCB	1.59e-05	3	53	2	CID000164152
Drug	daphnetoxin	PRKCA PRKCB	3.18e-05	4	53	2	CID000119454
Drug	thiram	PRKCA PRKCB MMP13	3.35e-05	27	53	3	CID000005455
Drug	Fura-2AM	PRKCA PRKCB NTN1 RYR3	3.45e-05	79	53	4	CID000105091
Drug	F-dd	FLNB DIAPH1 DIAPH3 RYR3	3.81e-05	81	53	4	CID006102682
Disease	autosomal dominant auditory neuropathy 1 (implicated_via_orthology)	DIAPH1 DIAPH3	9.49e-06	3	53	2	DOID:0060690 (implicated_via_orthology)
Disease	smoking behavior, BMI-adjusted waist circumference	KCTD19 LCORL COBLL1 CCDC92	6.96e-05	122	53	4	EFO_0004318, EFO_0007789
Disease	matrix metalloproteinase 7 measurement	MMP13 LILRB5	8.80e-05	8	53	2	EFO_0010591
Disease	trans fatty acid measurement, trans-16:1n-7 fatty acid measurement	DIAPH3 TEK	8.80e-05	8	53	2	EFO_0006821, EFO_0006822
Disease	body mass index, type 2 diabetes mellitus	COBLL1 ARAP1	3.74e-04	16	53	2	EFO_0004340, MONDO_0005148
Disease	alcohol use disorder (implicated_via_orthology)	PRKCA PRKCB ZNF683 RYR3	4.20e-04	195	53	4	DOID:1574 (implicated_via_orthology)
Disease	body fat percentage, type 2 diabetes mellitus	COBLL1 ARAP1	4.23e-04	17	53	2	EFO_0007800, MONDO_0005148
Disease	low density lipoprotein cholesterol measurement, body fat percentage	COBLL1 CCDC92	4.23e-04	17	53	2	EFO_0004611, EFO_0007800
Disease	matrix metalloproteinase 12 measurement	MMP13 LILRB5	4.75e-04	18	53	2	EFO_0010590
Disease	schizophrenia, inflammatory bowel disease	PRKCB INAVA	4.75e-04	18	53	2	EFO_0003767, MONDO_0005090
Disease	body mass index, high density lipoprotein cholesterol measurement	COBLL1 CCDC92	5.31e-04	19	53	2	EFO_0004340, EFO_0004612
Disease	triglyceride measurement, body mass index	COBLL1 CCDC92	5.31e-04	19	53	2	EFO_0004340, EFO_0004530
Disease	triglyceride measurement, body fat percentage	COBLL1 CCDC92	6.50e-04	21	53	2	EFO_0004530, EFO_0007800
Disease	gastric ulcer (biomarker_via_orthology)	TEK MMP13	6.50e-04	21	53	2	DOID:10808 (biomarker_via_orthology)
Disease	Primary familial hypertrophic cardiomyopathy	MYOZ2 NEXN	7.15e-04	22	53	2	cv:C0949658
Disease	body fat percentage, high density lipoprotein cholesterol measurement	COBLL1 CCDC92	9.25e-04	25	53	2	EFO_0004612, EFO_0007800
Disease	congestive heart failure (biomarker_via_orthology)	PRKCA PRKCB MMP13	9.52e-04	107	53	3	DOID:6000 (biomarker_via_orthology)
Disease	Glioblastoma Multiforme	BRD2 PRKCA PRKCB	1.06e-03	111	53	3	C1621958
Disease	ovarian carcinoma (is_marker_for)	PRKCA MMP13	1.16e-03	28	53	2	DOID:4001 (is_marker_for)
Disease	coronary artery disease	LCORL N4BP2L2 LRRC7 CCDC92 TEK COG5 MMP13 ANKRD55	1.23e-03	1194	53	8	EFO_0001645
Disease	insulin measurement	COBLL1 CCDC92 ARAP1 MYBL2	1.36e-03	267	53	4	EFO_0004467
Disease	anterior uveitis	KIFAP3 INAVA	1.52e-03	32	53	2	EFO_1000811
Disease	Chloracne	ZNF683 ANKRD55	1.61e-03	33	53	2	C0263454

Protein segments in the cluster

Peptide	Gene	Start	Entry
KTIKLKPSSLGKPLP	ACSM6	381	Q6P461
LYGPKKRGPKPKTFL	CBX6	66	O95503
APEKKKYRGPGKIVP	AFF2	691	P51816
YLKPKLGKKLRSDQP	FAM47DP	316	A6NHR8
YLLPEKKPLARKGLP	ANKRD55	416	Q3KP44
PVLPFGLTPKKLYKP	DIAPH1	761	O60610
PFGLKPKKEFKPEIS	DIAPH3	631	Q9NSV4
KPKAKAPLPPAETKY	COBLL1	16	Q53SF7
CPKIKPLKKYLLLGN	NTN1	546	O95631
PLAYKRKKKPPLSNG	INTS15	251	Q96N11
FKPYLPPKRAGTLKD	KCTD19	716	Q17RG1
KPVPKTYVPKLGKGD	NEXN	16	Q0ZGT2
KTLYKGVPLKPRKEL	ANOS1	176	P23352
LYPPKLVLLGKDKKE	LRRC7	651	Q96NW7
TPPKKKLRLPDTGLY	LCORL	571	Q8N3X6
APLKPKLNPKKARAY	FLNB	246	O75369
YPKKISELGLPKEVK	MMP13	366	P45452
KPKPPPRKYFKSDSD	IL16	596	Q14005
PSYVPAPLRKKKPDK	LMO7	321	Q8WWI1
KLPRTLYSQKLPKGP	LILRB5	161	O75023
LSDPYVKLKLIPDPK	PRKCB	191	P05771
KLKPKGSLPPKYALE	OAS2	556	P29728
LKVFDGIPPPYDKKK	RPL13AP3	16	Q6NVV1
KPKGLKKPYNPILGE	OSBPL8	476	Q9BZF1
FIPKKPDYDPEKALK	COG5	461	Q9UP83
LYGPKKRGPKPKTFL	CBX8	66	Q9HC52
KLNYKPPPQKSLKEL	ARHGDIB	21	P52566
KGKEPCKYDGIPPKT	DCDC2C	246	A8MYV0
LASYKPAPPKDKLPE	CCDC92	186	Q53HC0
RSLPEKGPPKALAYK	BFSP1	606	Q12934
PYSKLPGVSLLKPLK	UGCG	46	Q16739
LPAEYPLKPGEKAPK	INAVA	151	Q3KP66
KLVPYLKDKLKPGAA	KIFAP3	546	Q92845
LLSDKDPPKLKDYLP	MTBP	171	Q96DY7
YKGLPKYILPLKTPG	RPH3AL	156	Q9UNE2
LSDPYVKLKLIPDPK	PRKCA	191	P17252
PFKNALEKYGPLKPL	MYBL2	521	P10244
VLECPFYKGPKLLPK	FASTKD3	501	Q14CZ7
KKKKYEPPVPTRVGK	PSMC1	21	P62191
KRYSLAVGPPKKDPK	SPTY2D1	21	Q68D10
PDLPNLAYKKLKGKS	ABHD10	61	Q9NUJ1
CLRKKPRKPYTIKKP	BRD2	706	P25440
PRKPYTIKKPVGKTK	BRD2	711	P25440
SLKVYLGVKKKLRPP	ARAP1	1341	Q96P48
KLCALVYKIKGPPKP	RYR3	1926	Q15413
VEYKPPKKPFVKLKD	USP15	776	Q9Y4E8
FGDGPIKSKKLLYKP	TEK	471	Q02763
YPPDFDPSKIPKLKL	YJU2	11	Q9BW85
YPLLLPKGVVLKLKP	YY1AP1	426	Q9H869
KKHPDFPKKPLTPYF	UBTF	106	P17480
GKKLKTKALEPPAPR	USP40	21	Q9NVE5
TAALPYPLKKKNGKI	ZNF683	306	Q8IZ20
KAFIGPIYKPPEKKK	N4BP2L2	121	Q92802
AKPKPSKDLKPLLGS	MYORG	46	Q6NSJ0
LYPKLFKPEGKAELP	MYOZ2	166	Q9NPC6